Communiqués Prestige Consumer Healthcare Inc. Deutsche Boerse AG

Actions

PBV

US74112D1019

Temps Différé Deutsche Boerse AG Autres places de cotation 09:01:50 03/07/2024			Varia. 5j.	Varia. 1 janv.
63 ^EUR	+0,80%		-2,33%	+13,51%

21/06	PRESTIGE CONSUMER HEALTHCARE INC. : DA Davidson relève à l'achat	ZM
15/05	Mise à jour sectorielle : Les actions du secteur de la santé augmentent avant la cloche mercredi	MT

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results	02/07	GL
Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference	06/06	GL
Prestige Consumer Healthcare : Insider Trading Policy	20/05	PU
Prestige Consumer Healthcare : Q4 2024 Prestige Consumer Healthcare Inc. Earnings Conference Call Presentation	15/05	PU
Prestige Consumer Healthcare: Fiscal Q4 Earnings Snapshot	14/05	AQ
Prestige Consumer Healthcare Inc. Reports Fiscal Year 2024 Results	14/05	GL
Prestige Consumer Healthcare : Clawback Policy	25/04	PU
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results	25/04	GL
Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag	03/04	GL
Prestige Consumer Healthcare : Consumer Analyst Group of New York (CAGNY) 2024 Luncheon Presentation	07/03	PU
Prestige Consumer Healthcare: Fiscal Q3 Earnings Snapshot	08/02	AQ
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results	08/02	GL
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene	02/02	GL
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene	02/02	AQ
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results	10/01	GL
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results	10/01	AQ
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene	22/12	GL
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene	24/11	GL
Prestige Consumer Healthcare : Q2 2024 Prestige Consumer Healthcare Inc. Earnings Conference Call Presentation	02/11	PU
Prestige Consumer Healthcare: Fiscal Q2 Earnings Snapshot	02/11	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Prestige Consumer Healthcare Inc. Deutsche Boerse AG

Actions

PBV

US74112D1019

Communiqués

Filtres